- Home
- CERT vs BXMX Comparison
CERT vs BXMX Comparison
Compare CERT & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERT
- BXMX
- Stock Information
- Founded
- CERT 2008
- BXMX 2004
- Country
- CERT United States
- BXMX United States
- Employees
- CERT N/A
- BXMX N/A
- Industry
- CERT Retail: Computer Software & Peripheral Equipment
- BXMX Investment Managers
- Sector
- CERT Technology
- BXMX Finance
- Exchange
- CERT Nasdaq
- BXMX Nasdaq
- Market Cap
- CERT 1.7B
- BXMX 1.5B
- IPO Year
- CERT 2020
- BXMX N/A
- Fundamental
- Price
- CERT $11.70
- BXMX $13.86
- Analyst Decision
- CERT Buy
- BXMX
- Analyst Count
- CERT 6
- BXMX 0
- Target Price
- CERT $15.60
- BXMX N/A
- AVG Volume (30 Days)
- CERT 2.0M
- BXMX 205.6K
- Earning Date
- CERT 08-05-2025
- BXMX 01-01-0001
- Dividend Yield
- CERT N/A
- BXMX 7.24%
- EPS Growth
- CERT N/A
- BXMX N/A
- EPS
- CERT N/A
- BXMX N/A
- Revenue
- CERT $394,498,000.00
- BXMX N/A
- Revenue This Year
- CERT $11.57
- BXMX N/A
- Revenue Next Year
- CERT $8.93
- BXMX N/A
- P/E Ratio
- CERT N/A
- BXMX N/A
- Revenue Growth
- CERT 9.37
- BXMX N/A
- 52 Week Low
- CERT $8.64
- BXMX $11.75
- 52 Week High
- CERT $16.93
- BXMX $13.75
- Technical
- Relative Strength Index (RSI)
- CERT 55.84
- BXMX 65.09
- Support Level
- CERT $10.23
- BXMX $13.32
- Resistance Level
- CERT $12.41
- BXMX $13.87
- Average True Range (ATR)
- CERT 0.50
- BXMX 0.11
- MACD
- CERT 0.09
- BXMX 0.01
- Stochastic Oscillator
- CERT 67.40
- BXMX 87.27
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.